GT200200070A - Composiciones que contienen imidazotriazinona para administracion nasal - Google Patents

Composiciones que contienen imidazotriazinona para administracion nasal

Info

Publication number
GT200200070A
GT200200070A GT200200070A GT200200070A GT200200070A GT 200200070 A GT200200070 A GT 200200070A GT 200200070 A GT200200070 A GT 200200070A GT 200200070 A GT200200070 A GT 200200070A GT 200200070 A GT200200070 A GT 200200070A
Authority
GT
Guatemala
Prior art keywords
imidazotriazinone
compositions containing
nasal administration
gmpc
phosphodiesterases
Prior art date
Application number
GT200200070A
Other languages
English (en)
Inventor
Peter Serno
Andreas Ohm
Wolfgang Barth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200200070A publication Critical patent/GT200200070A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A COMPOSICIONES QUE CONTIENEN IMIDAZOTRIAZINONA PARA ADMINISTRACION NASAL DE FORMULA GENERAL (I) EN DONDE R1,R2,R3,R4,R5,R6, SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE. ESTOS COMPUESTOS VAN A CONTENER UNA PEQUEÑA CANTIDAD DE ANESTESICO LOCAL JUNTO CON LA IMIDAZOTRIAZINONA QUE COMO INHIBIDOR DE FOSFODIESTERASAS (PDE GMPC) SON UTILES EN LA DISFUNCION ERECTIL MASCULINA.
GT200200070A 2001-04-12 2002-04-11 Composiciones que contienen imidazotriazinona para administracion nasal GT200200070A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10118306A DE10118306A1 (de) 2001-04-12 2001-04-12 Imidazotriazinonhaltige Zusammensetzungen zur nasalen Applikation

Publications (1)

Publication Number Publication Date
GT200200070A true GT200200070A (es) 2003-01-31

Family

ID=7681379

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200200070A GT200200070A (es) 2001-04-12 2002-04-11 Composiciones que contienen imidazotriazinona para administracion nasal

Country Status (25)

Country Link
US (2) US6740306B2 (es)
EP (1) EP1381368A2 (es)
JP (1) JP2004525968A (es)
KR (1) KR20030087072A (es)
CN (1) CN1537004A (es)
AR (1) AR035821A1 (es)
BG (1) BG108245A (es)
BR (1) BR0208813A (es)
CA (1) CA2443639A1 (es)
CZ (1) CZ20032752A3 (es)
DE (1) DE10118306A1 (es)
DO (1) DOP2002000373A (es)
EC (1) ECSP034795A (es)
EE (1) EE200300501A (es)
GT (1) GT200200070A (es)
HU (1) HUP0303877A3 (es)
IL (1) IL158255A0 (es)
MX (1) MXPA03009314A (es)
NO (1) NO20034556L (es)
PE (1) PE20021035A1 (es)
PL (1) PL363033A1 (es)
RU (1) RU2003133143A (es)
SK (1) SK12682003A3 (es)
UY (1) UY27256A1 (es)
WO (1) WO2002083674A2 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4540295B2 (ja) * 2001-05-09 2010-09-08 バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト 2−フェニル置換イミダゾトリアジノンの新しい用途
DE102004023069A1 (de) * 2004-05-11 2005-12-08 Bayer Healthcare Ag Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
CN101083984B (zh) * 2004-12-23 2010-11-10 罗克斯罗制药公司 用于经鼻内投与酮咯酸(ketorolac)的治疗组合物
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
EP1898879A1 (en) * 2005-06-23 2008-03-19 Schering Corporation Rapidly absorbing oral formulations of pde5 inhibitors
SG166106A1 (en) * 2005-09-29 2010-11-29 Bayer Schering Pharma Ag Pde inhibitors and combinations thereof for the treatment of urological disorders
WO2008151734A1 (en) * 2007-06-13 2008-12-18 Bayer Schering Pharma Aktiengesellschaft Pde inhibitors for the treatment of hearing impairment
KR20110017433A (ko) * 2008-06-13 2011-02-21 록스로 파마 인코퍼레이티드 비강내 투여용 케토로락의 약학적 제형물
US8551454B2 (en) * 2009-03-13 2013-10-08 Luitpold Pharmaceuticals, Inc. Device for intranasal administration
US8277781B2 (en) * 2009-03-13 2012-10-02 Luitpold Pharmaceuticals, Inc. Device for intranasal administration
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
WO2020006606A1 (en) * 2018-07-05 2020-01-09 Helium 3 Resources Pty Ltd A pharmaceutical composition and method of use of same
SE542968C2 (en) * 2018-10-26 2020-09-22 Lindahl Anders Treatment of osteoarthritis
IL298432A (en) * 2020-05-26 2023-01-01 Strategic Drug Solutions Inc Formulations and methods for treating erectile dysfunction

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4602099A (en) * 1973-04-02 1986-07-22 Merrell Dow Pharmaceuticals Inc. Antirhinovirus agents
GB9013750D0 (en) 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9301192D0 (en) 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
GB9514465D0 (en) 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
GB9514473D0 (en) 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
EP0985671B1 (en) 1996-05-31 2003-04-02 Mochida Pharmaceutical Co., Ltd. PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT
GB2315673A (en) * 1996-08-01 1998-02-11 Merck & Co Inc Treatment of migraine
WO1998053819A1 (fr) * 1997-05-29 1998-12-03 Mochida Pharmaceutical Co., Ltd. Agent therapeutique destine a traiter l'anerection
AU9214498A (en) 1997-09-23 1999-04-12 Eli Lilly And Company Treatment of attention-deficit/hyperactivity disorder
HU230154B1 (hu) 1997-11-12 2015-09-28 Bayer Intellectual Property Gmbh Eljárás 2-es helyzetben fenil-szubszituenst hordozó imidazo-triazinon-származékok előállítására
TWI223598B (en) * 1998-06-22 2004-11-11 Pfizer Ireland Pharmaceuticals An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate
WO2000000199A1 (en) * 1998-06-26 2000-01-06 Nastech Pharmaceutical Company, Inc. Nasal delivery of sildenafil citrate
CN1149983C (zh) * 1998-12-14 2004-05-19 赛勒吉药物股份有限公司 用于治疗肛门直肠病的组合物和方法

Also Published As

Publication number Publication date
UY27256A1 (es) 2002-11-29
IL158255A0 (en) 2004-05-12
DOP2002000373A (es) 2002-11-30
HUP0303877A3 (en) 2005-05-30
JP2004525968A (ja) 2004-08-26
HUP0303877A2 (hu) 2004-03-29
WO2002083674A3 (de) 2003-01-09
SK12682003A3 (sk) 2004-03-02
EE200300501A (et) 2003-12-15
NO20034556D0 (no) 2003-10-10
NO20034556L (no) 2003-12-10
WO2002083674A2 (de) 2002-10-24
AR035821A1 (es) 2004-07-14
ECSP034795A (es) 2003-12-01
BG108245A (en) 2005-01-31
CA2443639A1 (en) 2002-10-24
KR20030087072A (ko) 2003-11-12
EP1381368A2 (de) 2004-01-21
US20040248891A1 (en) 2004-12-09
CZ20032752A3 (cs) 2004-01-14
DE10118306A1 (de) 2002-10-17
PL363033A1 (en) 2004-11-15
MXPA03009314A (es) 2004-03-10
PE20021035A1 (es) 2002-11-29
RU2003133143A (ru) 2005-04-10
US20030022894A1 (en) 2003-01-30
US6740306B2 (en) 2004-05-25
BR0208813A (pt) 2004-03-09
CN1537004A (zh) 2004-10-13

Similar Documents

Publication Publication Date Title
GT200200070A (es) Composiciones que contienen imidazotriazinona para administracion nasal
AR053412A1 (es) Compuestos inhibidores de la interaccion entre mdm2 y p53, un metodo de preparadcion, composicion farmaceutica y uso del compuesto para fabricar medicamentos
MXPA02011426A (es) Derivados de b-carbolina utiles como inhibidores de fosfodiesterasa.
SV1998000008A (es) Inhibisores de sulfamida-metaloproteasa. ref. ran 4070\114
GT200400092A (es) Preparacion y uso de derivados de alquilarilo para el tratamiento de la obesidad
PA8593001A1 (es) Derivados de pirimidina para el tratamiento del crecimiento celular anormal
GT200100137A (es) Pro-drogas de derivados de 4-fenil-piridina.
GT200500103A (es) 4-fenilamino-quinazolin-6-il-amidas
GT200400133AA (es) Derivados de pirrolo[3,4-c] pirazol, activos como inhibidores de quinasa, proceso para su preparacion y composiciones farmaceuticas que los comprenden. (solicitud fraccionaria no. 1, derivada de la patente no. pi-2004-0133).
ATE369370T1 (de) Substituierte 2h-(1,2,4)triazolo(4,3-a)pyrazine als gsk-3-inhibitoren
PA8596901A1 (es) Inhibidores de p38 y metodos de uso de ellos
GT200100132A (es) Derivados de pirazol
CY1107747T1 (el) Υποκατεστημενα τετρακυκλικα παραγωγα πυρρολοκινολονης χρησιμα ως αναστολεις της φωσφοδιεστερασης
PA8623101A1 (es) Compuestos farmaceuticamente activos
RS52945B (en) PHARMACEUTICAL FORMULATIONS AND THEIR APPLICATION IN THE TREATMENT OF WOMEN SEXUAL DYSFUNCTION
AR063925A1 (es) Antibacteriales 5-hidroximetil -oxazolidin-2-ona composicion farmaceutica que los comprende y su uso para tratar o prevenir infecciones bacterianas
PA8575601A1 (es) Procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso
BRPI0408353A (pt) composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto
ATE368666T1 (de) Pyrazolopyrimidinone und ihre verwendung als pde inhibitoren
GT200100251A (es) Procedimiento para la preparacion de imidazotriazinonas substituidas con sulfonamida
NO20033959D0 (no) Benzimidazoler som er nyttige i behandling av seksuell dysfunksjon
PA8589801A1 (es) Aminoalcoxiindoles
SV2007002357A (es) Derivado de quinolina, su uso, preparacion y medicamento que lo contiene ref. p-sv-79232/ug
GT200400248A (es) Proceso para la preparacion de inhibidores de tubulina
ATE246174T1 (de) Tosylprolin-derivate als thymidylat-synthase inhibitoren